Biosimilar Entry News Today

The Inflation Reduction Act of 2022 (the Act) includes prescription drug provisions that have significant implications for the pharmaceutical industry and Medicare beneficiaries, such...

To embed, copy and paste the code into your website or blog: Citing concerns about growing consolidation, reduced competition, and increasing prices, President Biden issued on July 9, 2021 a sweeping Executive Order containing 72 initiatives to address competition concerns in a number of industries, including pharmaceuticals, biotech, and healthcare. In his remarks at the signing of the July 9, 2021 Executive Order, President Biden focused on three specific initiatives, the first of which rela...